Tessera Therapeutics
Jonathan Soriano is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Senior Manager in Portfolio Program and Alliance Management at Tessera Therapeutics since July 2021. In this role, Jonathan manages target primed reverse transcription-based CART immuno-oncology programs, driving the execution of proof of concept projects and external collaborations while working closely with the Chief Technology Officer. Prior to this, Jonathan held positions at Cue Biopharma, advancing from Associate Scientist to Manager, where contributions included innovative methods in preclinical research and drug development. At MassBiologics, Jonathan was integral in producing antibodies and fusion proteins, while earlier research roles included investigating repair methods in animal models at Massachusetts General Hospital and exploring microbial interactions at Tufts University. Jonathan holds a Master of Science in Medical Sciences from Boston University School of Medicine and a Bachelor of Science in Biology from Tufts University.
This person is not in any teams
This person is not in any offices
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.